This funding round has closed.
Sign up for alerts when similar Health & Social Work funding opens.
Advancing innovation in accelerated cancer diagnosis
- Funding
- Contact funder
- Deadline
- 28 October 2026
- Location
- England
- Applications
- Applications closed
Overview
Innovate UK, on behalf of the Office for Life Sciences (OLS) Cancer Healthcare Goals programme, will invest up to £25.4 million in the clinical validation and evaluation of early cancer diagnostic technologies and devices. The OLS is a co-funder.
This is a grant competition. It suits teams that are developing tools to spot cancer earlier and need to test them properly in clinical settings.
The competition is open to collaborations only. A single organisation cannot apply on its own. To lead a project, your organisation must be a UK registered business, an academic institution or an NHS organisation.
Your consortium must also include at least one UK registered micro, small or medium sized enterprise that is claiming grant funding on the application. Build your partnership early, as this is a condition of entry.
The competition opened on 1 September 2026 at 9:30am UK time. It closes on 28 October 2026 at 11:00am UK time. The £25.4 million is the total fund shared across all funded projects, not the amount for each project.
Full opportunity details and the application route are on the Innovation Funding Service, which the funder's page links to.
Official source: https://www.ukri.org/opportunity/advancing-innovation-in-accelerated-cancer-diagnosis/. Last checked by GrantMatch on 16 October 2026.
Requirements to check
Who can apply:
Key requirements:
- Collaborations only; single applicants cannot apply
- Lead organisation must be a UK registered business, an academic institution or an NHS organisation
- Consortium must include at least one UK registered micro, small or medium sized enterprise claiming grant funding on the application
- Funds clinical validation and evaluation of early cancer diagnostic technologies and devices
This competition is open to collaborations only. To lead a collaborative project, your organisation must be a UK registered business, an academic institution or an NHS organisation. The consortium must include at least one UK registered micro, small or medium sized enterprise that is claiming grant funding on the application.
This summary may not include every exclusion. Check the full eligibility rules, including who and what the funder will not support.
Who is this for?
Collaborative teams of businesses, universities and NHS organisations developing early cancer diagnostic technologies or devices that need clinical validation.
Regions
No published award history for Innovate UK. Some funders do not publish their grants data.
Full details from Innovate UK
Innovate UK, on behalf of the OLS Cancer Healthcare Goals programme, will invest up to £25.4 million, to support the clinical validation and evaluation of early cancer diagnostic technologies and devices.
How to apply
Apply through the Innovation Funding Service, where the full opportunity details are held. The competition opened on 1 September 2026 at 9:30am UK time and closes on 28 October 2026 at 11:00am UK time. Your application must come from a collaboration.
Get notified about grants like this
Create a free account to receive alerts when new health & social work funding opens.
Create free accountSimilar grants open now
Related funding in compatible areas. Check each fund's eligibility and local restrictions.
NHS Cancer Programme - Innovation Open Call 4
NHS England
England
Materials Innovation Programme Digital Materials Sandpit
Engineering and Physical Sciences Research Council (EPSRC)
England
Sustainable Medicines Manufacturing Innovation: CR&D Round 2
Innovate UK
National (UK-wide)
£500,000 – £1,000,000
Centres of Excellence for Regulatory Science and Innovation
Medical Research Council (MRC)
National (UK-wide)
EIT Health: Innovation Validation Call 2027
Innovate UK Business Connect
England
Last updated: 28 October 2026